Livongo Health Readies For IPO Later This Year

Disease management startup Livongo Health (Livongo) is preparing for an initial public offering (IPO), having recently hired Morgan Stanley, Goldman Sachs, and J.P. Morgan Chase to underwrite it. Since its launch in 2014, Livongo has raised about $240 million over the course of six funding rounds.

The news comes as Livongo continues to prepare itself for further expansion, with one of its more recent moves having been the hiring of former Cerner president Zane Burke as its new CEO. Currently, Livongo has more than 600 employers enrolled in its chronic disease management programs, including CVS and Express Scripts. Additionally . . .